Glide Pharma, the pharmaceutical development and device firm, has appointed Dr Mark Carnegie-Brown as its new chief executive.

Dr Carnegie-Brown brings to Glide 25 years’ experience of the life sciences sector and was previously chief executive of Evolutec, a biological drug development business.

He has also served as chief executive of Aenova, a pharmaceutical tablet and capsule manufacturer, where he led the integration of the Swisscaps and Dragenopharm organisations.